Evaluation Of Dry Eye Disease Using Clinical Tests In Routine Opd Patients Schirmer Test, Tbut, Symptom Scoring.
Keywords:
Dry eye disease, Schemer test, TBUT, SymptomsAbstract
Background: Dry eye disease is typically referred to as a multifactorial disease because there are multiple causes for this disease. This is especially true when dry eye affects quality of life. With the Schemer test and TBUT, which are simple, readily available tests to evaluate dry eye, this disease is still, for the most part, left unappreciated.
Objectives: To assess dry eye disease among routine outpatient department (OPD) attendees by performing Schemer testing, tear break-up time (TBUT) assessment, and symptom scoring, and to determine the relationship between subjective symptoms and objective clinical findings to support timely and accurate diagnosis.
Methodology: this study conducted in Gajju Khan Medical College Swabi from jan 2023 to jan 2024. 100 patients aged 18 years or older who were visiting the outpatient department surveys were conducted during a typical workday. Participants were asked to provide informed consent, after which demographic information was collected. Patients were asked to complete a standardized symptom questionnaire, followed by the determination of TBUT (tear break-up time) and a Shimmer test. Dry eye levels were determined using symptom and test scores. The information was analyzed using SPSS software and the t-test or chi-squared test, where applicable; p < 0.05 was the level of statistical significance.
Results: A total of 100 patients were evaluated, with a mean age of 43.1 ± 13.4 years. Dry eye disease was identified in 72 patients (60%) based on combined diagnostic criteria. Abnormal TBUT was present in 67 patients (55.8%), while 48 patients (40%) showed reduced Schemer values. Symptom scoring categorized 26% as mild, 24% as moderate, and 10% as severe dry eye. Females demonstrated a significantly higher frequency of abnormal TBUT compared to males (p = 0.02). Symptom severity showed a strong positive correlation with reduced TBUT (p = 0.01) and a moderate correlation with low Schemer values (p = 0.03).
Conclusion: Dry eye disease was prevalent amongst attendees of OPD. There was significance in symptom scoring, TBUT, and Schmerz values; therefore, both subjective and objective measures are critical to enhance detection and management.
Downloads
References
Abd-Allah NM, Hassan AA, Omar G, Hamdy M, Abdelaziz STA, Abd El Hamid WM, et al. Dry eye in rheumatoid arthritis: relation to disease activity. Immunological medicine. 2020;43(2):92-7.
2. Abu EK, Ofori AO, Boadi-Kusi SB, Ocansey S, Yankah RK, Kyei S, et al. Dry eye disease and meibomian gland dysfunction among a clinical sample of type 2 diabetes patients in Ghana. African health sciences. 2022;22(1):293-302.
3. Chen Q, Wei Z, Wang L, Xu X, Wei Z, Zheng P, et al. Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study. Frontiers in medicine. 2022;9:831337.
4. de Paiva CS, Pflugfelder SC, Ng SM, Akpek EK. Topical cyclosporine A therapy for dry eye syndrome. The Cochrane database of systematic reviews. 2019;9(9):Cd010051.
5. Downie LE, Ng SM, Lindsley KB, Akpek EK. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease. The Cochrane database of systematic reviews. 2019;12(12):Cd011016.
6. Herbaut A, Liang H, Rabut G, Trinh L, Kessal K, Baudouin C, et al. Impact of Dry Eye Disease on Vision Quality: An Optical Quality Analysis System Study. Translational vision science & technology. 2018;7(4):5.
7. Huang W, Wen Z, Saglam MS, Huang L, Honkanen RA, Rigas B. Phospho-Sulindac (OXT-328) Inhibits Dry Eye Disease in Rabbits: A Dose-, Formulation- and Structure-Dependent Effect. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 2021;37(6):321-30.
8. Jariyakosol S, Uthaithammarat L, Chatwichaikul N, Kasetsuwan N, Chongpison Y. Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A. Clinical ophthalmology (Auckland, NZ). 2021;15:1775-82.
9. Kaiser T, Janssen B, Schrader S, Geerling G. Depressive symptoms, resilience, and personality traits in dry eye disease. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2019;257(3):591-9.
10. Kuklinski EJ, Hom MM, Ying GS, Lin MC, Chapkin RS, Jones R, et al. Associations Between Systemic Omega-3 Fatty Acid Levels With Moderate-to-Severe Dry Eye Disease Signs and Symptoms at Baseline in the Dry Eye Assessment and Management Study. Eye & contact lens. 2021;47(1):2-7.
11. Nagy A, Rentka A, Nemeth G, Ziad H, Szücs G, Szekanecz Z, et al. Corneal Manifestations of Systemic Sclerosis. Ocular immunology and inflammation. 2019;27(6):968-77.
12. Nkiru ZN, Stella O, Udeh N, Polycarp UA, Daniel CN, Ifeoma RE. Dry eye disease: A longitudinal study among pregnant women in Enugu, south east, Nigeria. The ocular surface. 2019;17(3):458-63.
13. Ongun N, Ongun GT. Is gabapentin effective in dry eye disease and neuropathic ocular pain? Acta neurologica Belgica. 2021;121(2):397-401.
14. Park SH, Hwang JS, Shin YJ. Effect of multivitamin drug on intractable dry eye symptoms. Frontiers in medicine. 2022;9:978107.
15. Petriček I, Pauk SV, Tomić M, Bulum T. Dry eye and dry skin - is there a connection? Ophthalmic epidemiology. 2023;30(1):7-16.
16. Prinz J, Maffulli N, Fuest M, Walter P, Hildebrand F, Migliorini F. Placebo administration for dry eye disease: a level I evidence based systematic review and meta-analysis. International journal of clinical pharmacy. 2022;44(5):1087-101.
17. Sahlu M, Giorgis AT. Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia. BMC ophthalmology. 2021;21(1):155.
18. Sánchez-González JM, De-Hita-Cantalejo C, Sánchez-González MC. Crosslinked hyaluronic acid with liposomes and crocin for management symptoms of dry eye disease caused by moderate meibomian gland dysfunction. International journal of ophthalmology. 2020;13(9):1368-73.
19. Sánchez-Valerio MDR, Mohamed-Noriega K, Zamora-Ginez I, Baez Duarte BG, Vallejo-Ruiz V. Dry Eye Disease Association with Computer Exposure Time Among Subjects with Computer Vision Syndrome. Clinical ophthalmology (Auckland, NZ). 2020;14:4311-7.
20. Son HS, Yildirim TM, Khoramnia R, Poompokawat P, Knorz MC, Auffarth GU. Semi-fluorinated Alkane Eye Drops Reduce Signs and Symptoms of Evaporative Dry Eye Disease After Cataract Surgery. Journal of refractive surgery (Thorofare, NJ : 1995). 2020;36(7):474-80.
21. Yan ZP. Dry eye symptoms and signs in children wearing OK lenses for six months in China. Journal francais d'ophtalmologie. 2020;43(3):211-5.
22. Zhang G, Fu W, Xu J, Hu P, Zhang Y, Sang Z, et al. Moxibustion with Walnut Shell Spectacles Could Improve the Objective Symptoms and Tear Film Stability of Patients with Dry Eye Disease: A Randomized Controlled Trial. Evidence-based complementary and alternative medicine : eCAM. 2022;2022:1773444.
.
.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
